Edenred: Another high conviction position at risk of getting taken out
BC Partners is looking to acquire Edenred
Introduction
For years, Edenred was viewed as one of Europe’s highest quality financial technology businesses. The company built a global network connecting employers, employees, merchants and mobility providers through meal vouchers, employee benefits, fleet solutions and corporate payments. The business generated recurring revenue, strong cash flow and attractive returns on capital. Edenred was valued as a growth stock with a PE ratio between 20-30.
Yet despite these characteristics, Edenred’s valuation has collapsed over the past two years, following concerns around Brazilian regulation, pressure on merchant fees in Italy, antitrust scrutiny and slowing growth. This has transformed a former market darling into one of the cheapest large-cap compounders in Europe, trading at just a forward PE of 11, with a 7x multiple at the bottom a few months ago.
I’ve been covering the company for a few years and have always been convinced of the quality of the business, despite regulatory pressures. Here’s my latest post, after the Brazil regulation sent the stock tumbling.
Over the last months of 2025, I started to develop a high conviction position into the polish logistics company InPost. Early January rumors started spreading about a PE take private attempt, which then got confirmed a month later. After Stemmer Imaging in 2024, this was the second time in a short time that private equity has taking one of my investments out.
Now Edenred confirmed that BC Partners is exploring a take private transaction and has been exploring the formation of a consortium. While no formal offer has been submitted, Edenred confirmed that it has been approached by investment funds.
It seems like I am good at finding take private candidates. It’s always bitter-sweet when it happens, because we basically trade the potential of long-term compounding for a high price premium. Unfortunately, often those offers are made if a company is going through depressed valuation multiples, as was the case with Stemmer Imaging, InPost and now potentially Edenred if a deal materializes.
Why Edenred Looks Attractive To Financial Buyers
Private equity firms rarely become interested in businesses by accident. The ideal target typically combines several characteristics:
Recurring revenue (meal vouchers are paid out monthly to employees)
High free cash flow conversion (Edenred converts FCF > NI)
Market leadership (around 40% market share)
Moderate leverage (1x net debt/EBITDA
Operational improvement opportunities (regulatory changes)
A temporary valuation discount (11x PE versus 20-30x historical range).
Edenred checks nearly every box.
The company operates in markets where scale matters. Once employers, merchants and employees are connected to the platform, switching becomes disruptive and costly. The result is a business that produces substantial recurring revenue and cash flow while requiring relatively modest capital expenditure.
Management has repeatedly highlighted the company’s strong free cash flow generation and long-term growth ambitions, including revenue targets extending into 2030. For a financial buyer, these characteristics create a predictable stream of cash that can support acquisition financing.
Why Public Markets Became Skeptical
If the business is so attractive, why has the stock performed so poorly? The answer lies largely in regulation.
Brazil remains the largest concern. Investors fear that reforms could increase competition and pressure economics within the meal voucher ecosystem.
Italy added pressures to margins through implementation of a commission cap. Meanwhile, antitrust scrutiny has raised questions about future pricing power and market structure.
None of these issues necessarily destroy Edenred’s business model, but they create uncertainty. Public markets generally dislike uncertainty and often apply significant valuation discounts until outcomes become clearer.
Private equity investors operate differently and are often willing to underwrite regulatory risks if they believe the market has become excessively pessimistic.
What Might Edenred Be Worth?
Following the takeover speculation, analysts suggested that a potential offer in the €27 to €28 range could represent a premium of roughly 30% to 35% versus pre-rumor trading levels. Interestingly, such a premium would still leave room for an argument that the business is being acquired below its long-term intrinsic value. In the following sections I’ll discuss how a take private offer might look like, factors speaking for an against a deal and my valuation framework for Edenred.